B-hTNFA mice

C57BL/6-Tnftm1(TNF)Bcgen/Bcgen • 110002

B-hTNC mice
B-hTNFA/hIL17A mice

B-hTNFA mice

Product nameB-hTNFA mice
Catalog number110002
Strain nameC57BL/6-Tnftm1(TNF)Bcgen/Bcgen
Strain backgroundC57BL/6
NCBI gene ID7124 (Human)
AliasesDIF-alpha, TNFA, TNFSF2, TNLG1F, TNF

このページで

  • Targeting strategy
  • Phenotypic analysis
  • Efficacy
  • Physiological data

ポスター

すべて表示

    出版物

      Targeting strategy

      Gene targeting strategy for B-hTNFA mice. The exons 1-4 of mouse Tnfa gene that encode signal peptide, extracellular domain, transmembrane domain and cytoplasmic region were replaced by human counterparts in B-hTNFA mice. The promoter, 5’UTR and 3’UTR region of the mouse gene were replaced by human counterparts. The human TNFA expression was driven by human TNFA promoter, while mouse Tnfa gene was knocked out.

      Protein expression analysis in serum

      Strain specific TNFA expression analysis in wild-type C57BL/6 mice and homozygous humanized B-hTNFA mice by ELISA. Serum was collected from wild-type C57BL/6 mice (+/+) and homozygous B-hTNFA mice (H/H) stimulated with LPS (20 μg/mice) in vivo for 1 hour (female, 8-week-old, n=3). Expression level of TNFA were analyzed by ELISA. Mouse TNFA was only detectable in wild-type C57BL/6 mice. Human TNFA was exclusively detectable in homozygous B-hTNFA mice. Values are expressed as mean ± SEM. ND: not detectable.

      Frequency of leukocyte subpopulations in spleen

      Frequency of leukocyte subpopulations in spleen by flow cytometry. Splenocytes were isolated from wild-type C57BL/6 mice and homozygous B-hTNFA mice (female, 8-week-old, n=3). A. Flow cytometry analysis of the splenocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequencies of T cell subpopulations. Percentages of T cells, B cells, NK cells, DCs, monocytes, macrophages, neutrophils, CD4+ T cells, CD8+ T cells and Tregs in B-hTNFA mice were similar to those in C57BL/6 mice, demonstrating that humanization of TNFA does not change the frequency or distribution of these cell types in spleen. Values are expressed as mean ± SEM.

      Frequency of leukocyte subpopulations in blood

      Frequency of leukocyte subpopulations in blood by flow cytometry. Blood cells were isolated from wild-type C57BL/6 mice and homozygous B-hTNFA mice (female, 8-week-old, n=3). A. Flow cytometry analysis of the blood cells was performed to assess the frequency of leukocyte subpopulations. B. Frequencies of T cell subpopulations. Percentages of T cells, B cells, NK cells, DCs, monocytes, macrophages, neutrophils, CD4+ T cells, CD8+ T cells and Tregs in B-hTNFA mice were similar to those in C57BL/6 mice, demonstrating that humanization of TNFA does not change the frequency or distribution of these cell types in blood. Values are expressed as mean ± SEM.

      Frequency of leukocyte subpopulations in lymph nodes

      Frequency of leukocyte subpopulations in lymph nodes by flow cytometry. Leukocytes were isolated from wild-type C57BL/6 mice and homozygous B-hTNFA mice (female, 8-week-old, n=3). A. Flow cytometry analysis of the leukocytes was performed to assess the frequency of leukocyte subpopulations. B. Frequencies of T cell subpopulations. Percentages of T cells, B cells, NK cells, CD4+ T cells, CD8+ T cells and Tregs in B-hTNFA mice were similar to those in C57BL/6 mice, demonstrating that humanization of TNFA does not change the frequency or distribution of these cell types in lymph nodes. Values are expressed as mean ± SEM.

      In vivo efficacy of anti-human TNFA antibody in CAIA model

      Efficacy of anti-human TNFA antibody in B-hTNFA mice with collagen antibody induced arthritis (CAIA) model. B-hTNFA mice (female, n=10, 9-10 weeks-old) were intravenously injected with collagen antibody (mAb) on Day 0, followed by intraperitoneally injection of LPS on day 3 (A). Body weight (B) and clinical score (C) were measured on Day 0 and daily from Day 3 to Day 20 of the study. The treatment group received either anti-human TNFA antibody Adalimumab analog (in house) or methotrexate (purchased from MCE). The model group (G2 group) exhibited an arthritis phenotype after LPS injection, and its clinical score stabilized after 8 days. This indicated that the CAIA model was successfully established in B-hTNFA mice.. The clinical score of Adalimumab analog (in house) treatment group and methotrexate (purchased from MCE) were significantly lower than those of the model group (G2 group). The results indicated B-hTNFA mice provide a powerful preclinical CAIA mouse model for in vivo evaluation of anti-human TNFA antibody.

      Hematology analysis

      Complete blood count (CBC) of B-hTNFA mice. Values are expressed as mean ± SD.

      Biochemistry analysis

      Biochemical test of B-hTNFA mice. Values are expressed as mean ± SD.

      Histopathological analysis

      Histopathological analysis of organs in B-hTNFA mice. The main organs of B-hTNFA mice and C57BL/6 mice (female, 8-week-old, n=10) were isolated and analyzed with H&E staining. Results showed that no obvious abnormalities were found in all of the organs (heart, liver, spleen, lung, kidney, brain, stomach, small intestine, large intestine, uterus and ovary). Scale bar: 100 μm.